News Oct 31, 2023 Debiopharm invests CHF 30 million in Valais amidst workforce surge Debiopharm Research & Manufacturing has announced an investment of over CHF 30 million in a Martigny lab expansion as staff numbers rise from 150...
News Oct 30, 2023 Compremium’s breakthrough medical device embarks on a NASA voyage Bern-based medtech innovator Compremium has delivered its pioneering Compartmental Compressibility Monitoring System to NASA, a significant leap ...
News Oct 27, 2023 UZH researchers develop method for transport of large genes Researchers at the University of Zurich (UZH) have developed a new method for transporting large genes, enabling them to be transferred efficient...
News Oct 27, 2023 Roche uses artificial intelligence for cancer diagnosis Roche is teaming up with Ibex Medical Analytics and Amazon Web Services in the field of artificial intelligence (AI). The goal is to help patholo...
News Oct 25, 2023 Mecaplast Swiss, 50 years of innovation in the canton of Fribourg With a rich history spanning five decades, Mecaplast Swiss has consistently proven itself as a leader in the plastic injection industry, particul...
News Oct 23, 2023 Valsynthèse, 40 years of innovation in the canton of Valais From dynamite to pharmaceuticals, Valsynthèse, the 'fine chemistry' business unit of the Société Suisse des Explosifs, celebrates four decades of...
News Oct 20, 2023 Xlife Sciences becomes main shareholder in 4D Lifetec Xlife Sciences, a listed accelerator and investor in innovative healthcare solutions, has made an investment totalling 23.3 million Swiss francs ...
News Oct 20, 2023 Lonza expands to manufacture Vaxcyte’s pneumococcal conjugate vaccine Lonza and US clinical-stage vaccine innovation company Vaxcyte have announced an expansion in their partnership to establish a global commercial ...
News Oct 19, 2023 Researchers reverse prostate cancer therapy resistance Researchers at the Institute of Oncology Research (IOR) have discovered how to reverse prostate cancer therapy resistance. This advancement came ...
News Oct 19, 2023 Mimix Biotherapeutics’ breakthrough tissue regeneration treatment receives strategic investment Biel-based Mimix Biotherapeutics announced the closure of a significant investment round, drawing participation from both European and Asian inve...
News Oct 18, 2023 BioArk Monthey’s third building signifies exponential growth in the life sciences sector With two decades under its belt, the BioArk site in Monthey continues to cement its position as a front-runner in life sciences.
News Oct 18, 2023 Cimeio collaborating with the University of Pennsylvania The Basel-based start-up Cimeio has been offered an exceptional opportunity for a preclinical research collaboration with the University of Penns...
News Oct 18, 2023 Siegfried and Lonza secure top positions in global pharmaceutical outsourcing rankings Valais-based pharmaceutical companies Lonza and Siegfried have been recognized among the leading players in the global outsourcing landscape, wit...
News Oct 17, 2023 Voltiris, Limula, and Parithera secure Biopôle’s Start-Up Fund Vaud-based start-ups Voltiris, Limula, and Parithera gain momentum in their innovative ventures as they secure vital funding and support from Bio...
News Oct 16, 2023 Adiposs completes the phase I clinical trial of its flagship product ImageBAT Geneva-based biotech Adiposs casts a ray of hope onto the horizons of cancer treatment and patient care with the successful conclusion of the Pha...
News Oct 11, 2023 Orio Therapeutics partners with Australia’s largest University to transform regenerative medicine In a stride towards redefining regenerative medicine, Monash University collaborates with Valais-based Orio Therapeutics to innovate in the realm...
News Oct 11, 2023 LimmaTech Biologics secures fresh capital of 37 million US dollars LimmaTech Biologics has raised 37 million US dollars as part of a Series A financing round. This should allow the company to finance the further ...
News Oct 11, 2023 Lonza further extends its ADC manufacturing capabilities in Visp Lonza amplifies ADC production via a robust extension in bioconjugation capacity at its Ibex Dedicate Biopark in Visp, which set to generate 180 ...